Neurology

Speaking about treating mental health symptoms linked to COVID-19 infection, Dr Abby Cheng reiterates the importance of validating the patient's experience.

Among study participants with migraine, investigators observed consistent and persistent device efficacy for pain relief, pain freedom, and functional disability freedom.

Ubrogepant 100 mg taken during the migraine prodrome significantly reduced onset of moderate or severe headache for 24 hours after study-drug dose.

Is the patient's low energy related to long COVID-related depression, post-exertional malaise, both? The differential diagnosis is all about nuance, says physiatrist Cheng.

Physiatrist Abby Cheng, MD, an author of the AAPM&R Long COVID Mental Health Consensus Guidance Statement, discusses why the symptoms can be confusing.

Simplified risk stratification tools for NAFLD, effects of statins on hepatic disease, trends in OHE, and patient perspectives are samples of the noteworthy research areas.

Cluster headache is rare and can be disabling. It can be misdiagnosed, particularly as migraine, but treatments are very different. Learn more in a short slide show.

Ailiani, director of MedStar Georgetown Headache Center, focuses on optimizing treatment with CGRP inhibitors and where research on PACAP-targeting agents stands now.

The 2022 AAFP Clinical Practice Guideline on hypertension treatment in adults is the subject matter for this 10-question topline quiz that is also a good source of review.

Your daily dose of the clinical news you may have missed.

The patient with neck pain might be better off referred to a physiatrist for additional evaluation and possibly treatment, according to PM&R physician Atul Patel, MD.

Your daily dose of the clinical news you may have missed.

What state has highest share of adult depression? Or the lowest divorce rate? Find the answers and more insights from a nationwide analysis, here.

In episodic migraine, both traditional oral OTC medications and newly approved classes led to significantly better improvements in pain compared with placebo.

Fatigue was positively correlated with frequency, duration, severity and chronicity of migraine episodes and more common among chronic migraineurs, a new study reveals.

Results from a new study show that older adults with untreated hypertension had a 42% increased risk of dementia vs healthy controls.

Your daily dose of the clinical news you may have missed.

A recent study of patients with chronic low back pain sheds light on the association between sleep and opioid use on pain severity and interference.

Women with an evening vs morning chronotype were 54% more likely to have unhealthy lifestyles that in turn accounted for a significant increased risk for diabetes.

Get a quick look at the US worst states for health care ranked using a composite score that included measures of cost, access, and outcomes.

Atrial fibrillation prevalence is rising across socioeconomic strata globally, the new analysis finds, with effects of BMI, ETOH, and sedentary behavior shifting as key drivers.

Your daily dose of clinical news you may have missed.

The first biosimilar to the approved formulation of natalizumab is indicated for relapsing forms of MS and for induction/maintenance of remission in adults with Crohn disease.

The device from Nexalin Technology outperformed placebo on key measures of pain relief, sleep quality, anxiety, and quality of life.

An overview of oral preventive medication options for migraine for primary care clinicians, here.

A daily dose of clinical news on Patient Care you may have missed.

The reduction in risk of CV events, the first to be shown by an antiobesity drug, was higher than expected and could help alter perceptions of the agents as "lifestyle drugs."

The oral gepant reduced monthly migraine days as well as mean monthly use of migraine rescue medication.

The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about?

The Alzheimer's Association chief science officer discusses release of updated diagnostic guidelines for AD, which incorporate use of plasma-based biomarkers.